Prevention of graft versus host disease with Hematopoietic CellTransplantation with Reduced Intensity Conditioning—a comparison of threeprophylaxis regimens (tacrolimus/mycophenolate mofetil/cyclophosphamide,tacrolimus/methotrexate/bortezomib or tacrolimus/methotrexate/maraviroc) versustacrolimus/me
暂无分享,去创建一个
N. Geller | P. Hari | M. Pasquini | Richard J. Jones | J. Pidala | J. Bolaños-Meade | J. Liesveld | Y. Efebera | Yi-Bin Chen | R. Sobecks | S. Solomon | R. Reshef | S. Arai | S. Holtan | I. Pusic | M. Fei | Z. Al-Kadhimi | J. Koreth | Juan | Noel | Wu | R. Fraser | K. Bickett | J. Bolaños-Meade | Professor Sunil Abhyankar | Professor Amin M. Alousi | Professor Joseph H. Antin | Professor Lloyd E. Damon | Professor Sergio A. Giralt | Professor Mary M. Horowitz | Professor David A. Jacobsohn | Professor Brent R. Logan | Professor Margaret L. MacMillan | Professor Marco Mielcarek | P. Pierre | Professor David L Porter | Professor Daniel J. Weisdorf